Ascension Asset Management’s AbbVie ABBV Stock Holding History

Ascension Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.61M	Sell	9,362 -650	-6%	-$108K	0.84%	42
2024 Q1	$1.82M	Buy	+10,012	New	+$1.73M	0.98%	37
2023 Q2	$1.42M	Buy	+10,512	New	+$1.54M	0.87%	46
2022 Q4	$1.7M	Hold	10,512	–	–	1.23%	36
2022 Q3	$1.41M	Hold	10,512	–	–	1.11%	41
2022 Q2	$1.61M	Buy	+10,512	New	+$1.61M	1.19%	39
2021 Q4	$1.45M	Sell	10,700 -300	-3%	-$35.4K	0.86%	47
2021 Q3	$1.19M	Sell	11,000 -50	-0.5%	-$5.71K	0.78%	53
2021 Q2	$1.25M	Sell	11,050 -394	-3%	-$44.4K	0.82%	53
2021 Q1	$1.21M	Buy	+11,444	New	+$1.22M	0.84%	52
2020 Q4	–	Sell	-11,569	Closed	-$1.01M	–	30
2020 Q3	$1.01M	Buy	+11,569	New	+$1.09M	0.81%	54
2020 Q1	$878K	Sell	11,519 -190	-2%	-$16.2K	0.91%	49
2019 Q4	$1.04M	Sell	11,709 -150	-1%	-$12.5K	0.89%	51
2019 Q3	$898K	Sell	11,859 -1,150	-9%	-$78.8K	0.83%	54
2019 Q2	$946K	Sell	13,009 -395	-3%	-$31K	0.83%	54
2019 Q1	$1.08M	Sell	13,404 -225	-2%	-$18.4K	0.97%	52
2018 Q4	$1.26M	Hold	13,629	–	–	1.28%	38
2018 Q3	$1.29M	Sell	13,629 -310	-2%	-$29.4K	1.13%	43
2018 Q2	$1.29M	Buy	13,939 +620	+5%	+$60.6K	1.18%	38
2018 Q1	$1.26M	Hold	13,319	–	–	1.15%	39
2017 Q4	$1.29M	Buy	+13,319	New	+$1.26M	1.17%	41

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ascension Asset Management's ABBV Position: Q2 2024 in Review

Ascension Asset Management reduced its AbbVie (ABBV) stake by 6.5% in Q2 2024, selling an estimated $108K and leaving 9,362 shares worth $1.61M. The position accounts for 0.84% of the portfolio, ranked #42.

Ascension Asset Management first reported a position in ABBV in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.82M in Q1 2024. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Ascension Asset Management held 9,362 shares of AbbVie worth $1.61M as of Q2 2024.
Ascension Asset Management sold 650 AbbVie shares in Q2 2024, an estimated $108K.
AbbVie made up 0.84% of Ascension Asset Management's portfolio in Q2 2024, its #42 holding.
Ascension Asset Management first reported a position in AbbVie in Q4 2017 and has held it in 21 quarters since.
Ascension Asset Management's AbbVie position peaked at $1.82M in Q1 2024.
3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Ascension Asset Management's 13F filing for Q2 2024, filed 16 Aug 2024.